Table 2.
Prevalence of headaches
| Prevalence of chronic headache | Prevalence of migraine | Prevalence of MOH | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total responders number | Number; % (95%CI) | Number; % (95%CI) | Number; % (95%CI) | |||||||
| 5864 | 2407 | 41.05% (39.79–42.31) | 250 | 4.26% (3.77–4.82) | 136 | 2.32% (1.96–2.73) | ||||
| Sex Women:Men (%Women) | 2883:2981 (49.16%) | 1647:760 (68.43%) | 202:48 (80.80%) | 110:26 (80.08%) | ||||||
| Age (median, IQR) (y.o.) | 47 (35–56) | 43 (31–52) | %Women | 43 (32–49) | %Women | 43 (36–49) | %Women | |||
| 15–19 | 498 | 203 | 40.76% (36.53–45.13) | 61.08% | 10 | 2.01% (1.04–3.71) | 50.00% | 10 | 2.01% (1.04–3.71) | 80.00% |
| 20–24 | 229 | 104 | 45.41% (39.10–51.89) | 60.58% | 8 | 3.49% (1.67–6.86) | 62.50% | 2 | 0.87% (0.03–3.34) | 0% |
| 25–29 | 343 | 197 | 57.43% (52.15–62.56) | 61.93% | 24 | 7.00% (4.71–10.24) | 66.67% | 8 | 2.33% (1.11–4.61) | 100% |
| 30–34 | 391 | 233 | 59.59% (54.66–64.34) | 64.81% | 34 | 8.70% (6.26–11.93) | 73.53% | 7 | 1.79% (0.79–3.72) | 100% |
| 35–39 | 508 | 278 | 54.72% (50.37–59.00%) | 66.55% | 32 | 6.30% (4.47–8.78) | 81.25% | 20 | 3.94% (2.53–6.04) | 75.00% |
| 40–44 | 587 | 306 | 52.13% (48.09–56.14%) | 68.30% | 38 | 6.47% (4.73–8.78) | 84.21% | 31 | 5.28% (3.72–7.42) | 83.87% |
| 45–49 | 825 | 380 | 46.04% (42.69–49.47%) | 68.95% | 33 | 4.00% (2.85–5.58) | 84.85% | 23 | 2.79% (1.84–4.17) | 73.91% |
| 50–54 | 769 | 259 | 33.68% (30.43–37.10%) | 77.22% | 28 | 3.64% (2.51–5.23) | 96.43% | 12 | 1.56% (0.86–2.74) | 91.67% |
| 55–59 | 758 | 237 | 31.27% (28.07–34.66%) | 72.57% | 28 | 3.69% (2.55–5.21) | 92.86% | 13 | 1.72% (0.97–2.94) | 84.62% |
| 60–64 | 956 | 210 | 21.97% (19.45–24.70%) | 75.71% | 15 | 1.57% (0.93–2.60) | 80.00% | 10 | 1.05% (0.54–1.94) | 70.00% |
Abbreviations: CI confident interval, IQR interquartile range, MOH medication-overuse headache